课题基金 / 基金详情

Modulation of Influenza Virus Replication and Fitness by Adenosine Deaminases

Modulation of Influenza Virus Replication and Fitness by Adenosine Deaminases
腺苷脱氨酶对流感病毒复制和适应性的调节
批准号:
9090008
负责人:
Balaji Manicassamy
金额:
$19.75万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2015
资助国家:
美国
项目状态:
已结题
起止时间:
2015-06-15 至 2017-05-31

项目摘要

项目成果

Balaji Manicassamy的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
 DESCRIPTION (provided by applicant): Influenza A virus (IAV) is an upper respiratory pathogen in humans that causes seasonal epidemics and sporadic pandemics[18-20]. Well known for its promiscuous host species tropism, IAV can infect waterfowl, domestic birds, swine, humans, and sea mammals[21]. IAV strains endemic to waterfowl and domestic animals are capable of spontaneously crossing the species barrier, leading to outbreaks in other host species and even pandemics in humans[22-25]. This adaptability is in part achieved through the inherent low fidelity of the encoded RNA dependent RNA polymerase; however, the host factors that contribute to efficient IAV transmission between species and/or maintain viral fitness upon infection of a new host remain unknown[26, 27]. We have recently identified ADAR1 as a host factor that is essential for optimal IAV replication and progeny fitness. We will further our understanding of the relationship between ADAR1 and IAV by (1) identifying and characterizing the mechanism(s) by which ADAR1 impacts influenza virus replication and progeny fitness, (2) determining the contribution of ADAR1 mediated editing of IAV genomic RNA to replication and evolution, and (3) investigating the role of ADAR1-NS1 interactions in controlling host species tropism and promoting adaptation. The knowledge gained from these studies will help to elucidate the mechanisms by which IAV usurps host proteins for proviral functions, particularly for viral evolution and adaptation, and allow us to apply these principals to other pathogenic viruses. This research will also lead to novel methods of surveillance, including identification of subtypes of NS1 in other species with the ability to cross the species barrier into humans. Furthermore, these studies will pave the way for development of host-directed antiviral therapeutics that can limit the capacity of IAV to adapt to new hosts during potentially pandemic situations.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Regulation of innate antiviral responses by the DNA-binding transcriptional repressor complex CIC-ATXN1/L
  • 批准号:
    10874145
  • 项目类别:
  • 资助金额:
    $7.78万
  • 财政年份:
    2022
  • 负责人:
    Balaji Manicassamy
  • 依托单位:
Regulation of innate antiviral responses by the DNA-binding transcriptional repressor complex CIC-ATXN1/L
  • 批准号:
    10671677
  • 项目类别:
  • 资助金额:
    $54.75万
  • 财政年份:
    2022
  • 负责人:
    Balaji Manicassamy
  • 依托单位:
Regulation of innate antiviral responses by the DNA-binding transcriptional repressor complex CIC-ATXN1/L
  • 批准号:
    10539709
  • 项目类别:
  • 资助金额:
    $54.75万
  • 财政年份:
    2022
  • 负责人:
    Balaji Manicassamy
  • 依托单位:
ENDOTHELIAL CELL TROPISM IN THE PATHOGENESIS AND HOST RESPONSE AGAINST INFLUENZA VIRUSES - RESUBMISSION 01
  • 批准号:
    9769437
  • 项目类别:
  • 资助金额:
    $55.63万
  • 财政年份:
    2017
  • 负责人:
    Balaji Manicassamy
  • 依托单位:
国内基金
海外基金
基于ADK/Adenosine调控DNA甲基化探讨“利湿化瘀通络”法对2型糖尿病肾病足细胞裂孔膜损伤的干预机制研究
  • 批准号:
    82074359
  • 项目类别:
    面上项目
  • 资助金额:
    55.0万元
  • 批准年份:
    2020
  • 负责人:
    安晓飞
  • 依托单位:
细胞外腺苷(Adenosine)作为干细胞旁分泌因子的生物学鉴定和功能分析
Adenosine诱导A1/A2AR稳态失衡启动慢性低灌注白质炎性损伤及其机制